EntrepreneurialCheck
Maddalena Adorno estimated net worth profile

Maddalena Adorno net worth

Maddalena Adorno Net Worth 2026 (Estimated) · Founder at Dorian Therapeutics · YC S18
est. wealth $7.5M

Quick answer

Maddalena Adorno's estimated net worth is $7.5M (range $5.25M – $11.25M) as of 2026. Maddalena Adorno is Founder at Dorian Therapeutics. Dorian Therapeutics valuation.

Maddalena Adorno is Founder at Dorian Therapeutics (YC S18). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameMaddalena Adorno
RoleFounder
CompanyDorian Therapeutics
YC batchS18
Est. company val$100.0M
Assumed ownership7.5%
Est. paper wealth / net worth$7.5M
$5.25M – $11.25M
  • Company status: Acquired
  • Education: Ph.D. from Harvard University
  • Region: United States of America
  • Industries: Healthcare, Therapeutics
  • Team size: 8
  • Website: http://www.doriantherapeutics.com

Who is Maddalena Adorno?

Maddalena Adorno is a co-founder of Dorian Therapeutics, a startup focused on cellular reprogramming for aging reversal.

Highlights:

  • Stanford University
  • Harvard University
  • Dorian Therapeutics

About Dorian Therapeutics

New therapeutics to rejuvenate tissue and treat age-related diseases

FAQ: Maddalena Adorno net worth and Dorian Therapeutics valuation

What is Maddalena Adorno's net worth?

Maddalena Adorno's estimated net worth is $7.5M (range $5.25M – $11.25M) as of 2026. Maddalena Adorno is Founder at Dorian Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Dorian Therapeutics valuation?

Dorian Therapeutics's estimated valuation on Entrepreneurial Check is $100.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Maddalena Adorno's role?

Maddalena Adorno is Founder at Dorian Therapeutics, a Y Combinator-backed startup (batch S18).